1,302
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Increasing but levelling out risk of revision due to infection after total hip arthroplasty: a study on 108,854 primary THAs in the Norwegian Arthroplasty Register from 2005 to 2019

, , , , , , , , , , , & show all

  • Amlie E, Havelin L I, Furnes O, Baste V, Nordsletten L, Hovik O, Dimmen S. Worse patient-reported outcome after lateral approach than after anterior and posterolateral approach in primary hip arthroplasty: a cross-sectional questionnaire study of 1,476 patients 1–3 years after surgery. Acta Orthop 2014; 85(5): 463–9.
  • Berg T, Løwer H L, Alberg T, Eriksen H M. (Norwegian) Årsrapport 2018 Helsetjenesteassosierte infeksjoner, antibiotikabruk (NOIS), antibiotikaresistens (MSIS) og Verdens håndhygienedag [in Norwegian]. Norwegian Institute of Public Health; 2019.
  • Brochin R L, Phan K, Poeran J, Zubizarreta N, Galatz L M, Moucha C S. Trends in periprosthetic hip infection and associated costs: a population-based study assessing the impact of hospital factors using national data. J Arthroplasty 2018; 33(7): 233–8.
  • Choi H J, Adiyani L, Sung J, Choi J Y, Kim H B, Kim Y K, Kwak Y G, Yoo H, Lee S O, Han S H, Kim S R, Kim T H, Lee H M, Chun H K, Kim J S, Yoo J D, Koo H S, Cho E H, Lee K W. Five-year decreased incidence of surgical site infections following gastrectomy and prosthetic joint replacement surgery through active surveillance by the Korean Nosocomial Infection Surveillance System. J Hosp Infect 2016; 93(4): 339–46.
  • Dale H, Hallan G, Espehaug B, Havelin L I, Engesaeter L B. Increasing risk of revision due to deep infection after hip arthroplasty. Acta Orthop 2009; 80(6): 639–45.
  • Dale H, Fenstad A M, Hallan G, Havelin L I, Furnes O, Overgaard S, Pedersen A B, Kärrholm J, Garellick G, Pulkkinen P, Eskelinen A, Mäkelä K, Engesaeter L B. Increasing risk of prosthetic joint infection after total hip arthroplasty. Acta Orthop 2012; 83(5): 449–58.
  • ECDC. Surveillance of surgical site infections and prevention indicators in European hospitals: HAISSI protocol. European Centre for Disease Prevention and Control; 2017. Available from https://www.ecdc.europa.eu/en/publications-data/surveillance-surgical-site-infections-and-prevention-indicators-european
  • ECDC. Healthcare-associated infections: surgical site infections. Annual Epidemiological Report for 2017. European Centre for Disease Prevention and Control; 2019. Available from https://www.ecdc.europa.eu/sites/default/files/documents/AER_for_2017-SSI.pdf.
  • Flurin L, Greenwood-Quaintance K E, Patel R. Microbiology of polymicrobial prosthetic joint infection. Diagn Microbiol Infect Dis 2019; 94(3): 255–9.
  • Furnes O, Hallan G, Gjertsen J E, Visnes H, Gundersen T, Fenstad A M, Dybvik E, Kroken G. The Norwegian Arthroplasty Register, Annual Report. Norwegian Arthroplasty Register; 2019. Available from http://nrlweb.ihelse.net/eng/Rapporter/Report2019_english.pdf
  • Gjertsen J E. Should total hip arthroplasty be used for hip fracture? N Engl J Med 2019; 381(23): 2261–2.
  • Gundtoft P H, Overgaard S, Schonheyder H C, Moller J K, Kjaersgaard-Andersen P, Pedersen A B. The “true” incidence of surgically treated deep prosthetic joint infection after 32,896 primary total hip arthroplasties. Acta Orthop 2015; 86(3): 326–34.
  • HastieT J, Tibshirani R J. Generalized additive models. London: Chapman & Hall; 1990.
  • Havelin L I, Engesaeter L B, Espehaug B, Furnes O, Lie S A, Vollset S E. The Norwegian Arthroplasty Register: 11 years and 73,000 arthroplasties. Acta Orthop Scand 2000; 71(4): 337–53.
  • Jämsen E, Nevalainen P, Eskelinen A, Huotari K, Kalliovalkama J, Moilanen T. Obesity, diabetes, and preoperative hyperglycemia as predictors of periprosthetic joint infection: a single-center analysis of 7181 primary hip and knee replacements for osteoarthritis. J Bone Joint Surg Am 2012; 94(14): 101–9.
  • Kurtz S M, Ong K L, Schmier J, Mowat F, Saleh K, Dybvik E, Kärrholm J, Garellick G, Havelin L I, Furnes O, Malchau H, Lau E. Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am 2007; 89(Suppl. 3): 144–51.
  • Kurtz S M, Lau E C, Son M S, Chang E T, Zimmerli W, Parvizi J. Are we winning or losing the battle with periprosthetic joint infection: trends in periprosthetic joint infection and mortality risk for the Medicare population. J Arthroplasty 2018; 33(10): 3238–45.
  • Lamagni T, Elgohari S, Harrington P. Trends in surgical site infections following orthopaedic surgery. Curr Opin Infect Dis 2015; 2(2): 125–32.
  • Lenguerrand E, Whitehouse M R, Beswick A D, Jones S A, Porter M L, Blom A W. Revision for prosthetic joint infection following hip arthroplasty: Evidence from the National Joint Registry. Bone Joint Res 2017; 6(6): 391–8.
  • Leong J W, Cook M J, O’Neill T W, Board T N. Is the use of antibiotic-loaded bone cement associated with a lower risk of revision after primary total hip arthroplasty? Bone Joint J 2020; 102-b(8): 997–1002.
  • Lie S A, Engesaeter L B, Havelin L I, Gjessing H K, Vollset S E. Dependency issues in survival analyses of 55,782 primary hip replacements from 47,355 patients. Stat Med 2004; 23(20): 3227–40.
  • Lindgren J V, Gordon M, Wretenberg P, Kärrholm J, Garellick G. Validation of reoperations due to infection in the Swedish Hip Arthroplasty Register. BMC Musculoskelet Disord 2014; 15: 384.
  • Liu W, Wahafu T, Cheng M, Cheng T, Zhang Y, Zhang X. The influence of obesity on primary total hip arthroplasty outcomes: a meta-analysis of prospective cohort studies. Orthop Traumatol Surg Res 2015; 101(3): 289–96.
  • Manniën J, van den H S, Muilwijk J, van den Broek P J, van Benthem B, Wille J C. Trends in the incidence of surgical site infection in the Netherlands. Infect Control Hosp Epidemiol 2008; 29(12): 1132–8.
  • Miller L E, Gondusky J S, Kamath A F, Boettner F, Wright J, Bhattacharyya S. Influence of surgical approach on complication risk in primary total hip arthroplasty. Acta Orthop 2018; 89(3): 289–94.
  • Mjaaland K E, Svenningsen S, Fenstad A M, Havelin L I, Furnes O, Nordsletten L. Implant Survival after minimally invasive anterior or anterolateral vs. conventional posterior or direct lateral approach: an analysis of 21,860 total hip arthroplasties from the Norwegian Arthroplasty Register (2008 to 2013). J Bone Joint Surg Am 2017; 99(10): 840–7.
  • Parvizi J, Saleh K J, Ragland P S, Pour A E, Mont M A. Efficacy of antibiotic-impregnated cement in total hip replacement. Acta Orthop 2008; 79(3): 335–41.
  • Parvizi J, Gehrke T, Chen A F. Proceedings of the International Consensus on Periprosthetic Joint Infection. Bone Joint J 2013; 95-b(11): 1450–2.
  • Parvizi J, Fassihi S C, Enayatollahi M A. Diagnosis of periprosthetic joint infection following hip and knee arthroplasty. Orthop Clin North Am 2016; 47(3): 505–15.
  • Parvizi J, Shohat N, Gehrke T. Prevention of periprosthetic joint infection: new guidelines. Bone Joint J 2017; 99-b(4 Suppl. B): 3–10.
  • Parvizi J, Tan T L, Goswami K, Higuera C, Della Valle C, Chen A F, Shohat N. The 2018 definition of periprosthetic hip and knee infection: an evidence-based and validated criteria. J Arthroplasty 2018; 33(5): 1309–14.
  • Pedersen A B, Mehnert F, Johnsen S P, Sørensen H T. Risk of revision of a total hip replacement in patients with diabetes mellitus: a population-based follow up study. J Bone Joint Surg Br 2010a; 92(7): 929–34.
  • Pedersen A B, Svendsson J E, Johnsen S P, Riis A, Overgaard S. Risk factors for revision due to infection after primary total hip arthroplasty: a population-based study of 80,756 primary procedures in the Danish Hip Arthroplasty Registry. Acta Orthop 2010b; 81(5): 542–7.
  • Perfetti D C, Boylan M R, Naziri Q, Paulino C B, Kurtz S M, Mont M A. Have periprosthetic hip infection rates plateaued? J Arthroplasty 2017; 32(7): 2244–7.
  • Ranstam J, Robertsson O. The Cox model is better than the Fine and Gray model when estimating relative revision risks from arthroplasty register data. Acta Orthop 2017; 88(6): 578–80.
  • Ranstam J, Kärrholm J, Pulkkinen P, Mäkelä K, Espehaug B, Pedersen A B, Mehnert F, Furnes O. Statistical analysis of arthroplasty data, I: Introduction and background. Acta Orthop 2011a; 82(3): 253–7.
  • Ranstam J, Kärrholm J, Pulkkinen P, Mäkelä K, Espehaug B, Pedersen A B, Mehnert F, Furnes O. Statistical analysis of arthroplasty data, II: Guidelines. Acta Orthop 2011b; 82(3): 258–67.
  • Sodhi N, Anis H K, Garbarino L J, Gold P A, Kurtz S M, Higuera C A, Hepinstall M S, Mont M A. Have we actually reduced our 30-day short-term surgical site infection rates in primary total hip arthroplasty in the United States? J Arthroplasty 2019; 34(9): 2102–6.
  • Ting N T, Della Valle C J. Diagnosis of periprosthetic joint infection: an algorithm-based approach. J Arthroplasty 2017; 32(7): 2047–50.
  • Varnum C, Pedersen A B, Gundtoft P H, Overgaard S. The what, when and how of orthopaedic registers: an introduction into register-based research. EFORT Open Reviews 2019; 4(6): 337–43.
  • Wang J, Zhu C, Cheng T, Peng X, Zhang W, Qin H, Zhang X. A systematic review and meta-analysis of antibiotic-impregnated bone cement use in primary total hip or knee arthroplasty. PLoS One 2013; 8(12): e82745.
  • Waugh H, Charnley J. The man and the hip. London: Springer Verlag; 1990; 153–69.
  • Zeller V A, Letembet V A, Meyssonnier V A, Heym B, Ziza J M, Marmor S D. Cutibacterium (fFormerly Propionibacterium) avidum: a rare but avid agent of prosthetic hip infection. J Arthroplasty 2018; 33(7): 2246–50.
  • Zhu Y, Zhang F, Chen W, Liu S, Zhang Q, Zhang Y. Risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis. J Hosp Infect 2015; 89(2): 82–9.